A Safe and Healthy Life

Leveraging our advanced technology, we contribute to the early diagnosis of diseases, quick recovery of health, and well-being.

06

About

We’re making a better future of the humanity
and science technology through ongoing research.

COMPANY

No.1 player

No.1 player in South Korea with over 70%
market share in allergy diagnostics

First

South Korea’s first
MP-CLIA technology INF-γ assay

Our products

We specialize in diagnostic reagents for allergies, tuberculosis, and respiratory diseases.

View
Immunodiagnostics01

Allergy

AdvanSure™ AlloScreen Max108 Panel

Allergy screening product that can test 108 types of allergen at once

View
Immunodiagnostics02

Latent TB

AdvanSure™ i3 TB-IGRA

Optimized solution for latent tuberculosis test in general hospitals

View
Molecular Diagnostics03

Respiratory Virus

AdvanSure™ RV-Plus real-time RT-PCR

Reagent for 15 types of respiratory
viruses test

View
Molecular Diagnostics04

TB/NTM

AdvanSure™ TB/NTM real-time PCR

Reagent for M. tuberculosis complex/
Nontuberculosis mycobacteria test

View
Molecular Diagnostics05

Nucleic Acid Extraction

AdvanSure™ E3 System

Automated nucleic acid extractor which can extract 48 samples within 15~35 minutes

View

CAREERS

We are looking for new talents!

More

INnovative

The ability to propose and create innovative and creative ideas.

VIsionary

The ability to foresee the future with a vision and take proactive steps.

TRailblazer

The ability to trailblaze new paths and drive innovative changes.

Open-minded
Synthesizer

Open-minded synthesizer who embraces and harmonizes diverse ideas.

News Room

Our latest news

View
Notice
LMCE 2024 exhibition & Education Workshop have been completed
 Invitros’ LMCE 2024 exhibition and Education Workshop have been successfully completed.We would like to extend our heartfelt gratitude to all attendees, and we look forward to your continued interest and support in the future.Thank you.
2024-10-02
Invitros (formerly known as LG Chem - diagnostics business division) releases significantly improved allergy reagent
Press Release
Invitros (formerly known as LG Chem - diagnostics business division) releases significantly improved allergy reagent
 LG Chem has launched a reagent that can check 93 allergy-causing substances, up sharply from the current 62, the company said Thursday.

In 2008, LG Chem released the “AdvanSure™ AlloScreen reagent,” a multi-drug substance-testing product, for the first time in Korea, through research and development on the diagnosis of allergies with Yonsei University Medical School.

The products launched this year added house dust mites, pollen allergies, and substances unique to Koreans through continuous research.

In particular, this reagent expands from 62 existing elements, enabling 93 kinds of materials to be inspected simultaneously with a drop of blood in three hours, saving time and cost of inspection, as well as providing food and the respiratory origin, while identifying the cause of the substance.

Allergies are types of autoimmune diseases that cause hypersensitivity reactions to external substances. It causes allergic asthma, eczema, and rhinitis, with symptoms such as a runny nose, and itchiness that distributes to many patients throughout the world.

Methods for treating allergies include the use of antihistamines, steroids, and immunotherapy, the most efficient and easiest way.

The domestic market is estimated to be about 25 billion won ($21 million), with the number of patients increasing every year due to the effects of fine dust and environmental hormones. Allergies caused by two or more causes are also increasing, making it necessary to know what causes allergens before they appear, the company said. (2017.08.10)

[Link: https://www.koreabiomed.com/news/articleView.html?idxno=1055]
2024-08-07